Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 18, 2023 09:42 ET | Source: The Insight Partners

Sharps Containers Market worth $725.1 Million by 2030 - Exclusive Report by The Insight Partners

Pune, India, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Sharps containers are made from rigid puncture-resistant plastic or metal with leak-resistant sides and bottom and a tight-fitting, puncture-resistant...
August 16, 2023 13:00 ET | Source: DelveInsight Business Research LLP

Wearable Injectors Global Market Size and Share to Rise at an Incredible CAGR of ~13% by 2028 | DelveInsight

New York, USA, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Wearable Injectors Global Market Size and Share to Rise at an Incredible CAGR of ~13% by 2028 | DelveInsight The wearable injectors market is...
August 16, 2023 02:19 ET | Source: Pharma Equity Group A/S

Consolidated interim report 1 January – 30 June 2023

16 August 2023 Announcement no. 38 Consolidated interim report 1 January – 30 June 2023 Key points (H1 2023) On 16 August 2023, the Board of Directors and Executive...
August 04, 2023 11:00 ET | Source: Precedence Research

Biopharmaceuticals Market Revenue to Reach USD 8,56,100 Million by 2030

Ottawa, Aug. 04, 2023 (GLOBE NEWSWIRE) -- The global biopharmaceuticals market revenue accounted for USD 3,73,600 million in 2023, a study published by Towards Healthcare a sister firm of Precedence...
August 03, 2023 07:05 ET | Source: Morphic Therapeutic

Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2023

-Reported positive topline results from EMERALD-1 study of MORF-057 in ulcerative colitis- -Continued enrollment on target in EMERALD-2 Phase 2b trial of MORF-057 in ulcerative colitis- -Greater...
July 28, 2023 11:11 ET | Source: CMI

Humira Biosimilar Market to surpass $3,871.4 Million by 2030, Globally, at a CAGR of 25.9%, says Coherent Market Insights (CMI)

Burlingame, July 28, 2023 (GLOBE NEWSWIRE) -- The global Humira biosimilar Market is approximated to be $772.1 million in 2023, and it is projected to reach $3,871.4 million by 2030 at a CAGR of...
July 27, 2023 08:00 ET | Source: Roivant Sciences

Telavant, a Roivant Company, Advances Inflammatory Bowel Disease Program with First Patient Dosed in Global Phase 2 Trial of Novel Anti-TL1A Antibody RVT-3101 in Crohn’s Disease

The Phase 2 TAHOE study, which is currently enrolling, evaluates the safety and efficacy of RVT-3101 in patients with moderate to severely active Crohn’s disease (CD)Roivant recently announced highly...
July 11, 2023 10:55 ET | Source: The Insight Partners

4.9% CAGR for Gastrointestinal Drugs Market Size Worth $71.3Bn, Globally, by 2027 with Irritable Bowel Syndrome Segment Driving Growth During 2020-2027 | Report by The Insight Partners

Pune, India, July 11, 2023 (GLOBE NEWSWIRE) -- The Insight Partners latest study on "Gastrointestinal Drugs Market Size Report, Forecast to 2027 – COVID-19 Impact and Global Analysis – by Drug...
July 11, 2023 06:50 ET | Source: Research Nester

Mesenchymal Stem Cells Market revenue to surpass USD 17 Billion by 2035, says Research Nester

New York, July 11, 2023 (GLOBE NEWSWIRE) -- The global mesenchymal stem cells market is slated to grow at a CAGR of ~14% between 2023 and 2035. The market is estimated to garner a revenue of ~USD 17...
July 04, 2023 15:15 ET | Source: Delvens

Microbiome Therapeutic Market to Expand at a CAGR of 31.1% and will Reach USD 1.2 Bn by 2030 Comprehensive Study by Delvens

Chicago, July 04, 2023 (GLOBE NEWSWIRE) -- The microbiome is a collection of genetic material derived from all of the bacteria that inhabit the human body. When compared to the human genome, the...